Eric Crombez serves as the Chief Medical Officer and Executive Vice President at Ultragenyx, where expertise in gene therapy and inborn errors of metabolism is applied. Previously, Eric held the position of Chief Medical Officer at Abeona Therapeutics and was a member of the Board of Directors. Additionally, Eric served as an FDA Industry Representative and Alternate Industry Representative for the FDA Cellular, Tissues, and Gene Therapies Advisory Committee. Prior experience also includes the role of Chief Medical Officer at Dimension Therapeutics.